These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 22166857)
1. A microchip flow-chamber system for quantitative assessment of the platelet thrombus formation process. Hosokawa K; Ohnishi T; Fukasawa M; Kondo T; Sameshima H; Koide T; Tanaka KA; Maruyama I Microvasc Res; 2012 Mar; 83(2):154-61. PubMed ID: 22166857 [TBL] [Abstract][Full Text] [Related]
2. Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions. Hosokawa K; Ohnishi T; Sameshima H; Miura N; Ito T; Koide T; Maruyama I Thromb Haemost; 2013 Jan; 109(1):102-11. PubMed ID: 23179055 [TBL] [Abstract][Full Text] [Related]
3. Studies of a microchip flow-chamber system to characterize whole blood thrombogenicity in healthy individuals. Yamaguchi Y; Moriki T; Igari A; Matsubara Y; Ohnishi T; Hosokawa K; Murata M Thromb Res; 2013 Aug; 132(2):263-70. PubMed ID: 23777751 [TBL] [Abstract][Full Text] [Related]
4. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques. Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511 [TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of direct thrombin and factor Xa inhibitors with antiplatelet agents under flow and static conditions: an in vitro flow chamber model. Hosokawa K; Ohnishi T; Sameshima H; Miura N; Koide T; Maruyama I; Tanaka KA PLoS One; 2014; 9(1):e86491. PubMed ID: 24497951 [TBL] [Abstract][Full Text] [Related]
6. Recombinant GPVI-Fc added to single or dual antiplatelet therapy in vitro prevents plaque-induced platelet thrombus formation. Mojica Muñoz AK; Jamasbi J; Uhland K; Degen H; Münch G; Ungerer M; Brandl R; Megens R; Weber C; Lorenz R; Siess W Thromb Haemost; 2017 Aug; 117(8):1651-1659. PubMed ID: 28569920 [TBL] [Abstract][Full Text] [Related]
7. Antithrombotic properties of pravastatin reducing intra-thrombus fibrin deposition under high shear blood flow conditions. Hamada M; Sugimoto M; Matsui H; Mizuno T; Shida Y; Doi M; Fukushima H; Nishio K; Yoshioka A; Shima M Thromb Haemost; 2011 Feb; 105(2):313-20. PubMed ID: 21136018 [TBL] [Abstract][Full Text] [Related]
8. Measurement of residual platelet thrombogenicity under arterial shear conditions in cerebrovascular disease patients receiving antiplatelet therapy. Yamazaki M; Ohnishi T; Hosokawa K; Yamaguchi K; Yoneyama T; Kawashima A; Okada Y; Kitagawa K; Uchiyama S J Thromb Haemost; 2016 Sep; 14(9):1788-97. PubMed ID: 27328457 [TBL] [Abstract][Full Text] [Related]
9. Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions. Hosokawa K; Ohnishi T; Miura N; Sameshima H; Koide T; Tanaka KA; Maruyama I Thromb Res; 2014 Jan; 133(1):66-72. PubMed ID: 24268424 [TBL] [Abstract][Full Text] [Related]
10. A novel automated microchip flow-chamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions. Hosokawa K; Ohnishi T; Kondo T; Fukasawa M; Koide T; Maruyama I; Tanaka KA J Thromb Haemost; 2011 Oct; 9(10):2029-37. PubMed ID: 21827607 [TBL] [Abstract][Full Text] [Related]
11. An additional mechanism of action of abciximab: dispersal of newly formed platelet aggregates. Marciniak SJ; Mascelli MA; Furman MI; Michelson AD; Jakubowski JA; Jordan RE; Marchese PJ; Frelinger AL Thromb Haemost; 2002 Jun; 87(6):1020-5. PubMed ID: 12083481 [TBL] [Abstract][Full Text] [Related]
12. Effects of the glycoprotein IIb/IIIa antagonist abciximab on thrombus formation and platelet function in cats with arterial injury. Bright JM; Dowers K; Powers BE Vet Ther; 2003; 4(1):35-46. PubMed ID: 12756634 [TBL] [Abstract][Full Text] [Related]
13. Platelets enhance lymphocyte adhesion and infiltration into arterial thrombus. Hu H; Zhu L; Huang Z; Ji Q; Chatterjee M; Zhang W; Li N Thromb Haemost; 2010 Dec; 104(6):1184-92. PubMed ID: 20838746 [TBL] [Abstract][Full Text] [Related]
14. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy. Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542 [TBL] [Abstract][Full Text] [Related]
15. Reduced effect of aspirin on thrombus formation at high shear and disturbed laminar blood flow. Barstad RM; Orvim U; Hamers MJ; Tjønnfjord GE; Brosstad FR; Sakariassen KS Thromb Haemost; 1996 May; 75(5):827-32. PubMed ID: 8725731 [TBL] [Abstract][Full Text] [Related]
16. Inhibition and reversal of platelet aggregation by alphaIIbbeta3 antagonists depends on the anticoagulant and flow conditions: differential effects of Abciximab and Lamifiban. Frojmovic M; Labarthe B; Legrand C Br J Haematol; 2005 Nov; 131(3):348-55. PubMed ID: 16225655 [TBL] [Abstract][Full Text] [Related]
17. Novel antiplatelet activity of protocatechuic acid through the inhibition of high shear stress-induced platelet aggregation. Kim K; Bae ON; Lim KM; Noh JY; Kang S; Chung KY; Chung JH J Pharmacol Exp Ther; 2012 Dec; 343(3):704-11. PubMed ID: 22984226 [TBL] [Abstract][Full Text] [Related]
18. Abciximab treatment in vitro after aspirin treatment in vivo has additive effects on platelet aggregation, ATP release, and P-selectin expression. Scazziota A; Altman R; Rouvier J; Gonzalez C; Ahmed Z; Jeske WP; Walenga JM; Fareed J Thromb Res; 2000 Dec; 100(6):479-88. PubMed ID: 11152927 [TBL] [Abstract][Full Text] [Related]
19. Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation. Goto S; Tamura N; Sakakibara M; Ikeda Y; Handa S Platelets; 2001 Nov; 12(7):406-14. PubMed ID: 11674857 [TBL] [Abstract][Full Text] [Related]
20. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA. McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]